Small-Cap Stock Outlook for 2024
Small-cap stocks have recently faced turbulence, but there seems to be a potential shift on the horizon as interest rates decline. Despite a challenging landscape, several small-cap companies have stood out, outperforming larger rivals and even doubling their share prices in the current fiscal year.
Let's delve into some of the remarkable small-cap performers so far. While the future remains unpredictable, as we enter December, these stocks are capturing attention due to their impressive achievements.
Included here are companies with market capitalizations ranging from $100 million to $2 billion that are actively traded on principal exchanges.
TSS Inc. - Up Nearly 3,700%
TSS Inc (NASDAQ: TSSI), also known as Total Site Solutions, specializes in providing comprehensive technology solutions for data centers and various tech environments. The company's robust platform incorporates modular edge services, data center services, and configuration services.
Since mid-August, TSS’s stock has skyrocketed, much to the excitement of market observers eager for data center companies like TSS, which typically lack extensive analyst coverage. A noteworthy highlight is the remarkable 689% increase in revenue year-over-year during the September quarter, underpinning the stock's tremendous ascent.
Bright Minds Biosciences – Up Nearly 2,600%
Bright Minds Biosciences Inc (NASDAQ: DRUG) is innovating in the treatment of central nervous system disorders. Currently, their leading candidate is under Phase 2 clinical trials for rare forms of epilepsy. The innovative BMB-101 acts as a selective 5-HT2C agonist, which may provide pro-cognitive effects during chronic dosing.
After primarily remaining stagnant this year, the shares of Bright Minds gained significant traction in late September following a successful $35 million non-brokered private placement involving notable investors.
Monopar Therapeutics – Up 1,400% YTD
Monopar Therapeutics Inc (NASDAQ: MNPR) is at the forefront of developing advanced cancer-targeted radiopharmaceuticals. The notable ALXN1840 for Wilson disease achieved its primary endpoint in Phase 3 trials. Furthermore, the company has established a partnership with Alexion and AstraZeneca for its late-stage Wilson disease candidate.
As for its other therapeutic agents, MNPR-101 is the furthest along, currently in a Phase 1 trial recruiting participants with advanced solid tumors.
The stock experience has been one for the books: shares leapt in mid-February, leveled off for several months, and then took off again in October following significant announcements, setting the stage for potential further rises.
Sezzle – Up Over 1,100% YTD
Sezzle Inc (NASDAQ: SEZL) is a pioneering company in the buy-now-pay-later sector, allowing consumers to make purchases and split payments into four interest-free installments over six weeks. They also offer longer-term installment plans for larger purchases.
The stock price saw a gradual increase throughout the year, significantly jumping in early November after a substantial earnings report where it beat expectations by over 200%, with revenue surpassing estimates as well.
Dave – Up Over 900%
Dave Inc (NASDAQ: DAVE) operates as a digital banking service focusing on cash advances through its mobile application. The platform has assisted over 6 million members in securing nearly 97 million cash advances.
Utilizing an AI-driven underwriting model, Dave evaluates more than 180 data points to assess advance eligibility, providing a more nuanced approach to cash flow management rather than relying on traditional credit scores. The stock value has been on the rise, especially after a prominent surge in November.
Honorable Mentions
A few notable small-cap companies have significantly increased in value this year despite having slightly lower market caps.
For instance, Synergy CHC Corp (NASDAQ: SNYR) has shown a remarkable rise, exceeding 4,400% in 2024. The consumer health company distributes various consumer products, which includes well-known brands.
Similarly, Nexalin Technology Inc (NASDAQ: NXL) has surged by 675%, navigating through notable volatility in its stock movement. Their unique offering aims to treat anxiety and insomnia with a non-invasive approach provided at home.
Potential for Small Caps Moving Forward
There's increasing buzz regarding the resurgence of small-cap stocks as interest rates begin to fall. Historical trends show that small caps often outperform larger stocks as the economy starts to recover, particularly in a declining inflation environment.
Investors recognize the promise of potentially high returns associated with small caps, albeit with accompanying risks. This trend is evident in the fluctuations seen in stock prices among some of these highlighted companies, showcasing the upside potential even amidst challenges.
As interest rates lower and economic indicators improve, experts predict that small-cap stocks may continue to gain appeal, but investors should conduct their research before proceeding with any investment strategy.
Frequently Asked Questions
What are small-cap stocks?
Small-cap stocks refer to companies with market capitalizations typically between $100 million and $2 billion that are traded on major exchanges.
Why are small-cap stocks experiencing growth?
Small-cap stocks are expected to benefit from declining interest rates and improving economic conditions, leading to increased investor interest.
How do small-cap stocks compare to large-cap stocks?
Small-cap stocks tend to offer higher growth potential but come with greater risks compared to stable large-cap stocks.
What should investors consider before investing in small caps?
Investors should assess their risk tolerance, conduct thorough research on individual companies, and keep an eye on market trends.
Which small-cap stocks are currently performing well?
Companies like TSS Inc, Bright Minds Biosciences, and Monopar Therapeutics have displayed impressive performance this year.
